Overview

Effects of IGF-I in HIV Metabolic Disease

Status:
Terminated

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

This study examines the effects of recombinant insulin like growth factor - I on body composition, glucose homeostasis, and lipids, in adults with HIV infection and signs of metabolic disease.

Phase:

Phase 1

Details

Lead Sponsor:

University of Texas Southwestern Medical Center

Treatments:

Mecasermin